About Fredun Pharmaceuticals Ltd
Data last updated:
Fredun Pharmaceuticals Ltd is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 June 1987 and has been in existence for over 39 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L24239MH1987PLC043662. Its GSTIN is 27AAACF0581A1Z7 (Maharashtra). The company holds 3 GST registrations, of which 2 are active. Its shares are listed on BSE: 539730.
The company has an authorised share capital of ₹50 Cr and a paid-up capital of ₹5.51 Cr. It was formerly known as Fredun Pharmaceuticals Private Limited. It is led by directors including Fredun Nariman Medhora (Managing Director) and Daulat Nariman Medhora (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹456.27 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹19.74 Cr (net margin 4.3%) and EBITDA of ₹54.91 Cr (EBITDA margin 12%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years and 32% over five years.
The company has about 388 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Fredun Group. As per MCA filings, the company has open charges of ₹293.76 Cr and satisfied charges of ₹172.61 Cr on record. Court records list 22 cases involving the company, including 6 filed by the company and 15 filed against it; 6 cases are pending. The company has 4 deals on record (3 market trades, 1 funding round), with disclosed funding of ₹80.55 Cr; the latest was in December 2025. Its 10 peer companies in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Zee Laboratories Limited. The company has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 418 overdue payments to 19 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fredungroup.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address11th Floor Tower A Urmi Estate, 95 Ganpatrao Kadam Marg Lower Parel (W), Mumbai, Maharashtra, India – 400013
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Fredun Pharmaceuticals Ltd
The main business activity of Fredun Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fredun Pharmaceuticals Ltd FY 2025 filings available
Fredun Pharmaceuticals Ltd reported revenue of ₹456.27 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Fredun Pharmaceuticals Ltd
Revenue has grown at a compounded annual rate (CAGR) of 32% over five years, including 31% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Fredun Pharmaceuticals Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹54.91 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.74 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Fredun Pharmaceuticals Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fredun Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zee Laboratories Limited | •••• | •••• | •••• | •••• | 404 | Delhi, India |
| Aristo Laboratories Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Tevapharm India Private Limited | •••• | •••• | •••• | •••• | 382 | Mumbai, Maharashtra, India |
| Jell Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 240 | Mumbai, Maharashtra, India |
| Biophore India Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 664 | Hyderabad, Telangana, India |
| Fredun Pharmaceuticals Ltd this company | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Hab Pharmaceuticals and Research Limited | •••• | •••• | •••• | •••• | 378 | Mumbai, Maharashtra, India |
| KLM Laboratories Private Limited | •••• | •••• | •••• | •••• | 2,104 | Mumbai, Maharashtra, India |
| Medispray Laboratories Private Limited | •••• | •••• | •••• | •••• | 684 | Goa, India |
| Copmed Pharmaceuticals Private Limited | •••• | •••• | •••• | •••• | 246 | New Delhi, Delhi, India |
| Hazelo Lab Private Limited | •••• | •••• | •••• | •••• | 252 | Chityal, Telangana, India |
Peers are the five companies nearest above and the five nearest below Fredun Pharmaceuticals by revenue in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Auditor Details of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd is audited by SAVLA & ASSOCIATES CHARTERED ACCOUNTANTS for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SAVLA & ASSOCIATES CHARTERED ACCOUNTANTS | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals has 6 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Daulat Nariman Medhora Also directs: Fredun Healthcare Private Limited, Fredun Retail Private Limited, Wagr Retail Private Limited and 2 more | Whole-Time Director | 08 Jun 1987 | 39 Years 3 Months | Current |
| Fredun Nariman Medhora Also directs: Fredun Healthcare Private Limited, Fredun Retail Private Limited, Wagr Retail Private Limited and 5 more | Managing Director | 15 Sep 2006 | 20 Years 0 Months | Current |
| Pooja Narendra Sanghavi | Additional Director | 28 Nov 2025 | 0 Years 10 Months | Current |
| Anshu Gyan Agarwal | Director | 30 Jul 2025 | 1 Years 2 Months | Current |
| Sonal Dharmin Desai | Director | 30 Jul 2025 | 1 Years 2 Months | Current |
| Daisy Cyril Dsouza Also directs: Sanjana Cryogenic Storages Limited | Director | 24 Nov 2023 | 2 Years 10 Months | Current |
Ownership and Shareholding of Fredun Pharmaceuticals Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Fredun Pharmaceuticals Ltd
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 May 2026 | Others | ₹2 Cr | Open |
| 30 Apr 2026 | Others | ₹1.06 Cr | Open |
| 15 Apr 2026 | Others | ₹35 Cr | Open |
| 26 Feb 2026 | Others | ₹20 Cr | Open |
| 22 Feb 2026 | Others | ₹3.78 Cr | Open |
Total charge records: 83 View all charges
Deals & Funding of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has 4 deals on record (3 market trades, 1 funding round), with disclosed funding of ₹80.55 Cr; the latest was in December 2025.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2025 | Funding round | ₹80.55 Cr | Investors: Alchemy Capital Management Private Limited , Instanow Info Systems Private Limited , Sona Vets Pvt Ltd |
| Sep 2021 | Market trade | ₹2.11 Cr | Seller: 2 individuals |
| Jul 2020 | Market trade | ₹6.33 Cr | Buyer: Kamal Kumar Jalan Sec. Pvt. Ltd, 2 individuals Seller: Kamal Kumar Jalan Sec. Pvt. Ltd, 2 individuals |
| Jan 2018 | Market trade | ₹22 Lakh | Seller: an individual |
Full deal history
All 4 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has 22 court cases on record: 6 filed by Fredun Pharmaceuticals, 15 filed against it, 1 where it is another party. 6 cases are pending and 16 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 19 | 15 | 5 |
| High courts | 3 | 0 | 1 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Valsad, Gujarat | Criminal complaint | Filed against the company by Yash Packaging Pvt Ltd | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against an individual | Pending |
| District court, Beed, Maharashtra | Court case (R.C.C.) | Filed against the company by State of Maharashtra | Pending |
| District court, West, Delhi | Commercial suit | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed by the company against an individual | Pending |
Full case history
All 22 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 418 overdue payments to 19 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 19)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Jasco Paper Products | •••• | •••• | •••• |
| Sarthak PVC World Private Limited | •••• | •••• | •••• |
| Shalibhadra Healthcare Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Promp + Tech Pharma Equipments (India) Private Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals operates one associated brand: Fredun Group. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of pharmaceutical formulations, APIs, and nutraceuticals | fredungroup.com |
Employees and EPFO Compliance at Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has a workforce of 388 employees as of Jan 08, 2026.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239MH1987PLC043662. The current CIN is L24239MH1987PLC043662, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24239MH1987PLC043662 | Current |
| U24239MH1987PLC043662 | Previous |
News related to Fredun Pharmaceuticals Ltd
Recent Activity on Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Ltd has 18 board changes on record since 1987: 13 appointments and 5 cessations. The latest: Pooja Narendra Sanghavi was appointed as Additional Director on 28 Nov 2025.
145 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Fredun Pharmaceuticals Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fredun Pharmaceuticals Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACF0581A1Z7 | Maharashtra | Active | 01 Jul 2017 |
| 07AAACF0581A1Z9 | Delhi | Active | 23 Apr 2024 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fredun Pharmaceuticals Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 June 1987 (39+ years old) and is registered under CIN L24239MH1987PLC043662. Listed on BSE: 539730.
Fredun Pharmaceuticals reported revenue of ₹456.27 Cr for FY 2025 (up 31% YoY).
Fredun Pharmaceuticals has 6 current directors:
- Fredun Nariman Medhora - Managing Director
- Daulat Nariman Medhora - Whole-Time Director
- Pooja Narendra Sanghavi - Additional Director
- Anshu Gyan Agarwal - Director
- Sonal Dharmin Desai - Director
- Daisy Cyril Dsouza - Director
Fredun Pharmaceuticals reported a net profit of ₹19.74 Cr (net margin 4.3%) and EBITDA of ₹54.91 Cr (EBITDA margin 12%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Fredun Pharmaceuticals is 26% over three years and 32% over five years. In the latest year (FY 2025) revenue rose 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Fredun Pharmaceuticals is 27AAACF0581A1Z7, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAACF0581A1Z9 (Delhi).
The CIN (Corporate Identification Number) of Fredun Pharmaceuticals is L24239MH1987PLC043662. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Fredun Pharmaceuticals is listed on BSE with code 539730.
Fredun Pharmaceuticals has 22 court cases on record: 6 filed by the company and 15 filed against it. 6 are pending. Most are in the district courts.
Fredun Pharmaceuticals was incorporated on 08 June 1987, making it 39+ years old. It is registered with the Registrar of Companies, Mumbai.
Fredun Pharmaceuticals has 4 deals on record (3 market trades, 1 funding round), with disclosed funding of ₹80.55 Cr; the latest was in December 2025.
The peers of Fredun Pharmaceuticals by revenue are Zee Laboratories Limited, Aristo Laboratories Private Limited, Tevapharm India Private Limited, Jell Pharmaceuticals Private Limited, Biophore India Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Animal Pharma, Formulations, Pharmaceuticals).